SAN FRANCISCO, Oct. 18, 2011 /PRNewswire/ -- ClinStar, LLC , an established CRO providing clinical research services in Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today that President and CEO David Passov and Manager of Clinical Operations Alexander Kutermin will speak at Global Engage's 3rd Oncology Clinical Trials in Emerging Regions  conference, November 3-4, in Philadelphia, PA.
According to the International Agency for Research on Cancer's (a division of the World Health Organization) GLOBOCAN 2008 report, an estimated 12.7 million people worldwide are diagnosed with some form of cancer annually and this number is expected to jump to 21 million by 2030. The emerging markets of Russia, Ukraine, Belarus and the Baltics offer access to a population of more than five million cancer sufferers. By conducting clinical trials in these regions, biopharmaceutical companies can significantly speed enrollment, and thereby, reduce the overall time and cost to develop an oncology drug.
During the presentation scheduled for Friday, November 4 at 1:30 p.m. , Mr. Passov will explore perceptions and comparisons of emerging markets and discuss how to navigate cultural and regulatory challenges in the region in order to optimize recruitment. Mr. Kutermin will present a case study revealing how Russia, Ukraine, Belarus and the Baltics outperformed 20+ other countries in a global, Phase III breast cancer trial.
Through a series of keynote regional presentations, case studies and interactive panel discussions, Global Engage's 3rd Oncology Clinical Trials in Emerging Regio